During the past decade, APEX GmbH conducted 23 clinical trials. In the 10-year time frame, 23 clinical trials started and 5 clinical trials were completed, i.e. on average, 21.7% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 5 clinical trials were completed. i.e. 41.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "APEX GmbH" #1 sponsor was "Gilead Sciences" with 5 trials, followed by "Bayer" with 4 trials sponsored, "Janssen Research & Development, LLC" with 3 trials sponsored, "CTI BioPharma" with 2 trials sponsored and "Idorsia Pharmaceuticals Ltd." with 2 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "APEX GmbH" #1 collaborator was "SGS S.A." with 2 trials as a collaborator, "Galapagos NV" with 1 trials as a collaborator and "Merck Sharp & Dohme LLC" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "APEX GmbH" are "Hepatic Impairment" (5 trials), "Healthy" (4 trials), "Renal Impairment" (3 trials), "Renal Insufficiency" (3 trials) and "HCV Infection" (2 trials). Many other conditions were trialed in "APEX GmbH" in a lesser frequency.

Most popular intervention types in "APEX GmbH" are "Drug" (24 trials). Other intervention types were less common.

The name of intervention was led by "Pacritinib" (2 trials), "Pimodivir" (2 trials), "Voxilaprevir" (2 trials), "ACT-1014-6470 40 mg" (1 trials) and "ACT-541468" (1 trials). Other intervention names were less common.

The vast majority of trials in "APEX GmbH" are 24 trials for "All" genders.

Currently, there are NaN active trials in "APEX GmbH". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 19 completed trials in APEX GmbH, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in APEX GmbH, 24 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".